207 related articles for article (PubMed ID: 28741505)
1. Emerging Roles for Eosinophils in the Tumor Microenvironment.
Reichman H; Karo-Atar D; Munitz A
Trends Cancer; 2016 Nov; 2(11):664-675. PubMed ID: 28741505
[TBL] [Abstract][Full Text] [Related]
2. Eosinophils in the Tumor Microenvironment.
Mattei F; Andreone S; Marone G; Gambardella AR; Loffredo S; Varricchi G; Schiavoni G
Adv Exp Med Biol; 2020; 1273():1-28. PubMed ID: 33119873
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles of eosinophils in cancer.
Simon SCS; Utikal J; Umansky V
Cancer Immunol Immunother; 2019 May; 68(5):823-833. PubMed ID: 30302498
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils in Colorectal Cancer: Emerging Insights into Anti-Tumoral Mechanisms and Clinical Implications.
Lopez-Perez D; Prados-Lopez B; Galvez J; Leon J; Carazo A
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892286
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma.
Kataoka S; Konishi Y; Nishio Y; Fujikawa-Adachi K; Tominaga A
DNA Cell Biol; 2004 Sep; 23(9):549-60. PubMed ID: 15383175
[TBL] [Abstract][Full Text] [Related]
6. A new dawn for eosinophils in the tumour microenvironment.
Grisaru-Tal S; Itan M; Klion AD; Munitz A
Nat Rev Cancer; 2020 Oct; 20(10):594-607. PubMed ID: 32678342
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?
Jacobsen EA; Taranova AG; Lee NA; Lee JJ
J Allergy Clin Immunol; 2007 Jun; 119(6):1313-20. PubMed ID: 17481717
[TBL] [Abstract][Full Text] [Related]
8. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme.
Koliaraki V; Henriques A; Prados A; Kollias G
J Exp Med; 2020 Apr; 217(4):. PubMed ID: 32044979
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors.
Lotfi R; Lee JJ; Lotze MT
J Immunother; 2007 Jan; 30(1):16-28. PubMed ID: 17198080
[TBL] [Abstract][Full Text] [Related]
10. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
11. Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice.
Samoszuk M; Deng T; Hamamura MJ; Su MY; Asbrock N; Nalcioglu O
Am J Pathol; 2004 Aug; 165(2):449-56. PubMed ID: 15277219
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma.
Robinson DS; North J; Zeibecoglou K; Ying S; Meng Q; Rankin S; Hamid Q; Tavernier J; Kay AB
Int Arch Allergy Immunol; 1999; 118(2-4):98-100. PubMed ID: 10224350
[TBL] [Abstract][Full Text] [Related]
13. Mast cell: insight into remodeling a tumor microenvironment.
Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
[TBL] [Abstract][Full Text] [Related]
14. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
Mould AW; Matthaei KI; Young IG; Foster PS
J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365
[TBL] [Abstract][Full Text] [Related]
15. Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer.
Wang L; Zhu B; Zhang M; Wang X
Semin Cell Dev Biol; 2017 Apr; 64():90-97. PubMed ID: 27639893
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.
Carretero R; Sektioglu IM; Garbi N; Salgado OC; Beckhove P; Hämmerling GJ
Nat Immunol; 2015 Jun; 16(6):609-17. PubMed ID: 25915731
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor cells and tumor microenvironment on NK-cell function.
Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
[TBL] [Abstract][Full Text] [Related]
19. Immune mediators in the tumor microenvironment of prostate cancer.
Dai J; Lu Y; Roca H; Keller JM; Zhang J; McCauley LK; Keller ET
Chin J Cancer; 2017 Mar; 36(1):29. PubMed ID: 28292326
[TBL] [Abstract][Full Text] [Related]
20. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH
Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
